Alibaba is raising HK$12 billion ($1.53 billion) through zero-interest exchangeable bonds, convertible into shares of its listed unit, Alibaba Health. This low-cost financing method allows the tech giant to fund strategic expansions in cloud services, AI, and global e-commerce without adding traditional debt to its balance sheet. The move aligns with a growing trend among Chinese tech firms utilizing equity-linked instruments to secure capital for future growth initiatives.
Alibaba is executing a sophisticated capital raise of HK$12 billion ($1.53 billion) through zero-interest exchangeable bonds, a low-cost financing strategy that avoids direct balance sheet debt. The bonds are exchangeable for shares in its 64%-owned subsidiary, Alibaba Health, allowing the company to monetize a portion of its holding without losing control. This move is part of a broader trend among Chinese technology firms, including Baidu's $2 billion bond tied to Trip.com shares, which leverage equity holdings to fund growth. The proceeds are explicitly earmarked for strategic priorities: expanding its cloud and AI capabilities and accelerating its global e-commerce footprint in key markets such as Thailand, Mexico, and South Korea. This follows a significant $5 billion bond deal in November 2024, indicating a sustained and aggressive investment cycle. The strategy is strongly endorsed by market analysts, who maintain a "Strong Buy" consensus with 13 Buy ratings against one Hold, and an average price target of $164.14 that implies approximately 51% upside potential from current levels.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment